Lilly Bengaluru HEOR/Evidence Synthesis - Consultant/ Senior Consultant at Eli Lilly and Company

Bengaluru, Karnataka, India

Eli Lilly and Company Logo
Not SpecifiedCompensation
Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Provide technical expertise and share scientific insights while planning, writing, editing, and reviewing HTA documents, ensuring high-quality standards
  • Conduct quality checks to ensure the accuracy of data included in documents
  • Collate reviewer’s comments, adjust document content based on internal/external input, and prepare the final version
  • Provide deliverables (e.g., reimbursement dossier) or therapy area expertise
  • Exhibit flexibility in moving across development and preparation of multiple document types
  • Work with teams to ensure smooth and timely development of documents
  • Influence or negotiate change of timelines and content with other team members
  • Maintain and enhance therapeutic area knowledge including disease state and compound for assigned project
  • Maintain advanced knowledge of health outcomes-related research, including RWE studies, reimbursement dossiers, value message development, economic evaluation, patient-reported outcome studies, etc
  • Possess an overarching view of the compound, therapeutic area, and external environment (including competitors)
  • Lead scientific data disclosure planning, clinical planning, submission strategy planning, customer regulatory responses, and/or current awareness literature updates and reviews
  • Provide informal coaching to others by sharing technical information, giving guidance, and answering questions
  • Network with others to identify and share best practices globally, articulate industry trends, and implement relevant projects/processes to optimize project planning and execution
  • Support cross-functional coaching, mentoring, and training
  • Ensure compliance with appropriate internal and external standards and policies
  • Represent the Lilly Bengaluru HEOR capability on key cross-functional teams
  • Provide leadership and coach

Responsibilities

  • Document Preparation / Document Management (40%)
  • Knowledge and Skills Development (30%)
  • Operational and Organizational Leadership (25%)
  • Collaborate with HEOR teams, specifically International HTA, Therapy Area teams, and Project Management for project execution
  • Act as a subject matter expert for a brand or therapeutic area
  • Responsible for the development of team capabilities
  • Provide functional influence and coordination across therapy area teams

Skills

HEOR
Health Economics
Outcomes Research
Real-World Evidence
RWE
Health Technology Assessment
HTA
Evidence Synthesis
Project Management

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI